![Load image into Gallery viewer, CBD + THC Gummies - 30 COUNT](http://leehemp.com/cdn/shop/files/grape-gummies-copycopy_110x110_crop_center.jpg?v=1683347388)
![Load image into Gallery viewer, CBD + THC Gummies - 30 COUNT](http://leehemp.com/cdn/shop/files/IMG_5673_1_110x110_crop_center.jpg?v=1683347388)
![Load image into Gallery viewer, CBD + THC Gummies - 30 COUNT](http://leehemp.com/cdn/shop/files/straw-thc-gummies-copy_110x110_crop_center.jpg?v=1683347388)
![Load image into Gallery viewer, CBD + THC Gummies - 30 COUNT](http://leehemp.com/cdn/shop/files/IMG_5666_1_110x110_crop_center.jpg?v=1683347388)
CBD + THC Gummies - 30 COUNT
Regular price
$32.00
Unit price per
Premium CBD+THC Gummies
25mg CBD + 10mg THC per Gummy - 30 CBD Gummies per Bottle
For treatment of symptoms including:
Pain - Anxiety - Sleep Disorders
Strong and tasty, our strawberry & grape flavored CBD + Delta9 THC Gummies provide a sense of calm and relaxation when you treat yourself to one!
- Vegan
- Pure CBD + Delta9 THC isolate
- Third-party tested for quality and purity
- Must be 21 years or older to purchase
Ingredients: Organic Tapioca, Organic Cane Sugar, Fruit Pectin, Citric Acid, Vegetable & Fruit Powders (color), Fruit Oils (flavor), Sodium Citrate, Coconut Oil, CBD isolate and THC isolate from organically grown hemp
ADULT USE ONLY. Not for sale to persons under 21 years of age.
WARNING: Do not drive or operate heavy machinery after consuming this product. May cause drowsiness. Do not combine with alcohol. Use responsibly and follow Suggested Use guidelines.
ADULT USE ONLY. Not for sale to persons under 21 years of age.
WARNING: Do not drive or operate heavy machinery after consuming this product. May cause drowsiness. Do not combine with alcohol. Use responsibly and follow Suggested Use guidelines.
Scientific Studies
- CBD’s anti-anxiety properties / potential use for substance abuse disorders (British Journal of Pharmacology)
- Antitumor effects of CBD (National Library of Medicine)
- Antitumor activity on human breast carcinoma (National Library of Medicine)
- Anti-inflammatory, antioxidant properties of CBD (National Library of Medicine)
- Antiseizure properties of CBD (National Library of medicine)
- CBD in the treatment of post-traumatic stress disorder (PTSD) (National Library of Medicine)
- Chronic pain management (National Library of Medicine)
- Neuroprotective properties / oxidative stress / Alzheimer’s disease (Wiley Online Library)
- Anti-cancer / Anti-tumor potential (National Library of Medicine)
- Anxiety and Sleep (National Library of Medicine)
- Anti-bacterial properties (National Library of Medicine)
- Analgesic / myofascial pain relief (National Library of Medicine)Anti-bacterial properties
- Arthritis inflammation and pain (National Library of Medicine)
- Psoriasis / Inflammation relief (National Library of Medicine)
- Suppression of nausea and vomiting (National Library of Medicine)
- Antidepressant-like effect of delta9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa
- Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission
- CBC, delta-9-THC and antidepressant effects (British Journal of Pharmacology)
- Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey
- The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions
- Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy
- CBC oil and analgesic, anti-inflammatory, anti-cancer effects (National Library of Medicine)
- CBC and pain relief (National Library of Medicine)
- Anti-inflammatory properties (National Library of Medicine)
- Anti-inflammatory / analgesic properties (British Journal of Pharmacology)
- Neural stem / progenitor cells / brain function (National Library of Medicine)
- Acne treatment (National Library of Medicine)
- Neuroprotective properties for seizure, hypomobility, Huntington’s and Parkinson’s diseases (British Journal of Pharmacology)